請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29130完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 賴凌平(Ling-Ping Lai) | |
| dc.contributor.author | Chun-Wu Chen | en |
| dc.contributor.author | 陳俊吾 | zh_TW |
| dc.date.accessioned | 2021-06-13T00:41:54Z | - |
| dc.date.available | 2012-08-08 | |
| dc.date.copyright | 2007-08-08 | |
| dc.date.issued | 2007 | |
| dc.date.submitted | 2007-07-25 | |
| dc.identifier.citation | 參考文獻 (References)
Acalovschi, M., A. Ciocan, et al. (2006). 'Are plasma lipid levels related to ABCG5/ABCG8 polymorphisms?: A preliminary study in siblings with gallstones.' European Journal of Internal Medicine 17(7): 490-494. Alrefai, W. A., F. Annaba, et al. (2007). 'Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: role of sterol regulatory element binding protein 2.' Am J Physiol Gastrointest Liver Physiol 292(1): G369-376. Altmann, S. W., H. R. Davis, Jr., et al. (2004). 'Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption.' Science 303(5661): 1201-1204. Chang, T.-Y., C. C. Y. Chang, et al. (2006). 'Cholesterol Sensing, Trafficking, and Esterification.' Annual Review of Cell and Developmental Biology 22(1): 129-157. Chang, T.-Y., P. C. Reid, et al. (2005). 'Niemann-Pick Type C Disease and Intracellular Cholesterol Trafficking.' J. Biol. Chem. 280(22): 20917-20920. Chouinard Jr, R. A., Y. Luo, et al. (1998). 'Sterol Regulatory Element Binding Protein-1 Activates the Cholesteryl Ester Transfer Protein Gene in Vivo but Is Not Required for Sterol Up-regulation of Gene Expression.' J. Biol. Chem. 273(35): 22409-22414. Christenson, L. K., T. F. Osborne, et al. (2001). 'Conditional Response of the Human Steroidogenic Acute Regulatory Protein Gene Promoter to Sterol Regulatory Element Binding Protein-1a.' Endocrinology 142(1): 28-36. Cohen, J. C., A. Pertsemlidis, et al. (2006). 'Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels.' PNAS 103(6): 1810-1815. Davies, J. P., B. Levy, et al. (2000). 'Evidence for a Niemann-Pick C (NPC) Gene Family: Identification and Characterization of NPC1L1.' Genomics 65(2): 137-145. Davies, J. P., C. Scott, et al. (2005). 'Inactivation of NPC1L1 Causes Multiple Lipid Transport Defects and Protects against Diet-induced Hypercholesterolemia.' J. Biol. Chem. 280(13): 12710-12720. Davis, H. R., Jr., L. M. Hoos, et al. (2007). 'Deficiency of Niemann-Pick C1 Like 1 Prevents Atherosclerosis in ApoE-/- Mice.' Arterioscler Thromb Vasc Biol 27(4): 841-849. Davis, H. R., Jr., L.-j. Zhu, et al. (2004). 'Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis.' J. Biol. Chem. 279(32): 33586-33592. Duval, C., V. Touche, et al. (2006). 'Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine.' Biochemical and Biophysical Research Communications 340(4): 1259-1263. Eberle, D., B. Hegarty, et al. (2004). 'SREBP transcription factors: master regulators of lipid homeostasis.' Biochimie 86(11): 839-848. ` Edwards, P. A., D. Tabor, et al. (2000). 'Regulation of gene expression by SREBP and SCAP.' Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1529(1-3): 103-113. Epand, R. M. (2006). 'Cholesterol and the interaction of proteins with membrane domains.' Progress in Lipid Research 45(4): 279-294. Ericsson, J., A. Usheva, et al. (1999). 'YY1 Is a Negative Regulator of Transcription of Three Sterol Regulatory Element-binding Protein-responsive Genes.' J. Biol. Chem. 274(20): 14508-14513. Field, F. J., K. Watt, et al. (2007). 'Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells.' J. Lipid Res.: M700029-JLR200. Garcia-Calvo, M., J. Lisnock, et al. (2005). 'The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).' PNAS 102(23): 8132-8137. Gauthier, B., M. Robb, et al. (1999). 'Characterization of a cholesterol response element (CRE) in the promoter of the cholesteryl ester transfer protein gene: functional role of the transcription factors SREBP-1a, -2, and YY1.' J. Lipid Res. 40(7): 1284-1293. Hawes, B. E., K. A. O'Neill, et al. (2007). 'In Vivo Responsiveness to Ezetimibe Correlates with Niemann-Pick C1 Like-1 (NPC1L1) Binding Affinity: Comparison of Multiple Species NPC1L1 Orthologs.' Mol Pharmacol 71(1): 19-29. Horton, J. D. (2002). 'Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis.' Biochem. Soc. Trans. 30(Pt 6): 1091-1095. Horton, J. D., J. L. Goldstein, et al. (2002). 'SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.' J. Clin. Invest. 109(9): 1125-1131. Huff, M. W., R. L. Pollex, et al. (2006). 'NPC1L1: Evolution From Pharmacological Target to Physiological Sterol Transporter.' Arterioscler Thromb Vasc Biol 26(11): 2433-2438. Hui, D. Y. and P. N. Howles (2005). 'Molecular mechanisms of cholesterol absorption and transport in the intestine.' Seminars in Cell & Developmental Biology 16(2): 183-192. Kuwabara, P. E. and M. Labouesse (2002). 'The sterol-sensing domain: multiple families, a unique role?' Trends in Genetics 18(4): 193-201. Lyer, S. P. N., X. Yao, et al. (2005). 'Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein.' Biochimica et Biophysica Acta (BBA) - General Subjects 1722(3): 282-292. Millard, E. E., S. E. Gale, et al. (2005). 'The Sterol-sensing Domain of the Niemann-Pick C1 (NPC1) Protein Regulates Trafficking of Low Density Lipoprotein Cholesterol.' J. Biol. Chem. 280(31): 28581-28590. Norata GD, C. A. (2004). 'Lipid lowering activity of drugs affecting cholesterol absorption.' Nutr Metab Cardiovasc Dis. 14((1)): 42-51. Ohgami, N., D. C. Ko, et al. (2004). 'Binding between the Niemann-Pick C1 protein and a photoactivatable cholesterol analog requires a functional sterol-sensing domain.' PNAS 101(34): 12473-12478. Oram, J. F. and A. M. Vaughan (2006). 'ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease.' Circ Res 99(10): 1031-1043. Pisciotta, L., T. Fasano, et al. (2007). 'Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients.' Atherosclerosis In Press, Corrected Proof. Rigotti, A., H. E. Miettinen, et al. (2003). 'The Role of the High-Density Lipoprotein Receptor SR-BI in the Lipid Metabolism of Endocrine and Other Tissues.' Endocr Rev 24(3): 357-387. Ross, R. (1999). 'Atherosclerosis -- An Inflammatory Disease.' N Engl J Med 340(2): 115-126. Santosa, S., K. A. Varady, et al. (2007). 'Physiological and therapeutic factors affecting cholesterol metabolism: Does a reciprocal relationship between cholesterol absorption and synthesis really exist?' Life Sciences 80(6): 505-514. Shea-Eaton, W., D. Lopez, et al. (2001). 'Yin Yang 1 Protein Negatively Regulates High-Density Lipoprotein Receptor Gene Transcription by Disrupting Binding of Sterol Regulatory Element Binding Protein to the Sterol Regulatory Element.' Endocrinology 142(1): 49-58. Simon, J. S., M. C. Karnoub, et al. (2005). 'Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment.' Genomics 86(6): 648-656. Sudhop, T., D. Lutjohann, et al. (2005). 'Sterol transporters: targets of natural sterols and new lipid lowering drugs.' Pharmacology & Therapeutics 105(3): 333-341. Trigatti, B. L., M. Krieger, et al. (2003). 'Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis.' Arterioscler Thromb Vasc Biol 23(10): 1732-1738. van der Veen, J. N., J. K. Kruit, et al. (2005). 'Reduced cholesterol absorption upon PPAR{delta} activation coincides with decreased intestinal expression of NPC1L1.' J. Lipid Res. 46(3): 526-534. Viturro, E. d. O., Manuel Lasuncion, Miguel A.; Gorgojo, Lydia ; Moreno, Jose M. Martin , M. Benavente, et al. (2006). 'Cholesterol and saturated fat intake determine the effect of polymorphisms at ABCG5/ABCG8 genes on lipid levels in children. Original Articles ' Genetics in Medicine 8((9):): 594-599. von Bergmann, K., T. Sudhop, et al. (2005). 'Cholesterol and Plant Sterol Absorption: Recent Insights.' The American Journal of Cardiology 96(1, Supplement 1): 10-14. Wang, D. Q. H. (2007). 'Regulation of Intestinal Cholesterol Absorption.' Annual Review of Physiology 69(1): 221-248. Wang, J., C. M. Williams, et al. (2005). 'Compound heterozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe.' Clinical Genetics 67(2): 175-177. Weiqing Tang, Y. M. L. Y. (2006). 'Plasma cholesterol is hyperresponsive to statin in ABCG5/ABCG8 transgenic mice.' Hepatology 44(5): 1259-1266. Yamanashi, Y., T. Takada, et al. (2007). 'Niemann-Pick C1-Like 1 Overexpression Facilitates Ezetimibe-Sensitive Cholesterol and beta-Sitosterol Uptake in CaCo-2 Cells.' J Pharmacol Exp Ther 320(2): 559-564. Yu, L., S. Bharadwaj, et al. (2006). 'Cholesterol-regulated Translocation of NPC1L1 to the Cell Surface Facilitates Free Cholesterol Uptake.' J. Biol. Chem. 281(10): 6616-6624. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29130 | - |
| dc.description.abstract | 中文摘要
目的: 本篇研究目的在找出國人NPC1L1基因的多形性,並進ㄧ步探討這些基因多形性變異對血脂濃度變化的影響。 背景: NPC1L1的生理功能為協助小腸細胞對於膽固醇的吸收,然而國人於NPC1L1序列上的基因多形性變異,以及它們對於人體的影響目前仍不清楚。 方法: 首先,本實驗隨機收集50個DNA檢體,藉由DHPLC以及DNA定序,針對NPC1L1的啟動子以及密碼區域序列進行基因多形性變異偵測。之後,進ㄧ步利用luciferase assay針對NPC1L1的啟動子序列多形性變異進行功能性分析。此外,本實驗進一步收集224個案,進行NPC1L1基因多形性變異與血脂濃度變化的相關研究。 結果: 本篇實驗總共發現11個基因多形性變異分布於NPC1L1基因序列內。其中,以g.-762T>C (啟動子區域多形性變異)以及g.1679C>G (L272L,同質多形性變異)在國人較為常見,比例分別為34% 以及 36% 。這兩個基因多形性變異呈現高度連鎖性的關係(D’ 值 = 0.7459,P 值 < 0.00001)。針對g.-762T>C (啟動子多形性變異),藉由進行luciferase assay分析的結果顯示,-762C對偶基因比-762T具有較高的啟動子活性(1.30 ± 0.22 vs 0.37 ± 0.06,3.5倍,P < 0.05)。本實驗也證實,-762C以及-762T兩種基因型的建構質體,其NPC1L1的啟動子活性都會受到膽固醇濃度變化加以調控。此外,相關的研究中也顯示,在隱性基因遺傳模式下,-762C對偶基因與血脂中總膽固醇以及低密度脂蛋白-膽固醇的濃度變化呈現顯著相關(LDL-C數值 = 131.2 ± 8.1 mg/dL vs 116.4 ± 2.2 mg/dL; total cholesterol 數值 = 214.7 ± 9.0 mg/dL vs 196.9 ± 2.6, P 值 < 0.05, n = 224)。 結論: 在國人的NPC1L1基因序列內,-762C對偶基因是相當常見的。-762C對偶基因具有較高的啟動子活性,另外也會使血脂中總膽固醇以及低密度脂蛋白-膽固醇呈現較高濃度的情況。 | zh_TW |
| dc.description.abstract | Abstract
Objective: The aims of this study were to identify genetic polymorphisms of the Niemann-Pick C1-like 1 (NPC1L1) gene and to investigate whether these polymorphisms were associated variations in serum cholesterol levels. Background: NPC1L1 is responsible for intestinal cholesterol absorption while gene variations in NPC1L1 gene and their effects on serum cholesterol levels remain unclear. Methods: We screened the promoter and coding regions of the NPC1L1 gene for genetic polymorphisms by DHPLC and direct DNA sequencing of genomic DNA from 50 individuals. Functional studies on promoter polymorphisms were performed using luciferase assay. Association between the polymorphisms and serum cholesterol levels was investigated in 224 individuals. Result: There were totally 11 single nucleotide polymorphisms identified. Among them, a promoter polymorphism g.-762T>C and a synonymous polymorphism g.1679C>G were common (34% and 36% respectively). These two polymorphisms were highly linked (D’ value = 0.7459, P value < 0.00001). For the g.-762T>C promoter polymorphism, luciferase assay in HepG2 cell line demonstrated that the -762C allele had a significantly higher promoter activity than the -762T allele (1.30 ± 0.22 vs 0.37 ± 0.06, 3.5-fold, p<0.05). We also showed that NPC1L1 promoter activity was regulated by cholesterol contents in both genotypes. When association studies were performed, we found that the -762C allele was associated with significantly higher serum total cholesterol and LDL-cholesterol levels in a recessive model (LDL-C value = 131.2 ± 8.1 mg/dL vs 116.4 ± 2.2 mg/dL; total cholesterol value = 214.7 ± 9.0 mg/dL vs 196.9 ± 2.6, P value < 0.05, n = 224). Conclusion: The C allele at -762 position of the NPC1L1 gene was common in Chinese. The -762C allele had a higher promoter activity and was associated with higher serum total cholesterol and LDL-C levels. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T00:41:54Z (GMT). No. of bitstreams: 1 ntu-96-R94443010-1.pdf: 3505968 bytes, checksum: b40ea3156ba85f5367f853154133d279 (MD5) Previous issue date: 2007 | en |
| dc.description.tableofcontents | 目錄
口試委員審定書------------------------------------- i 誌謝----------------------------------------------- ii 中文摘要------------------------------------------- iii 英文摘要------------------------------------------- iv 縮寫表--------------------------------------------- v 序論----------------------------------------------- 1 材料與方法----------------------------------------- 28 實驗結果------------------------------------------- 43 討論----------------------------------------------- 57 結論與展望----------------------------------------- 66 參考文獻------------------------------------------- 68 | |
| dc.language.iso | zh-TW | |
| dc.subject | 低密度脂蛋白-膽固醇 | zh_TW |
| dc.subject | 膽固醇 | zh_TW |
| dc.subject | 高密度脂蛋白-膽固醇 | zh_TW |
| dc.subject | 基因多形性 | zh_TW |
| dc.subject | Cholesterol | en |
| dc.subject | SNP | en |
| dc.subject | HDL-C | en |
| dc.subject | LDL-C | en |
| dc.title | NPC1L1基因多形性對血中膽固醇濃度的影響 | zh_TW |
| dc.title | The Influence of Niemann Pick type C-1 Like 1 Gene polymorphism on Serum Cholesterol levels | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 95-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 蘇銘嘉,楊偉勳,蘇怡寧 | |
| dc.subject.keyword | 膽固醇,低密度脂蛋白-膽固醇,高密度脂蛋白-膽固醇,基因多形性, | zh_TW |
| dc.subject.keyword | Cholesterol,LDL-C,HDL-C,SNP, | en |
| dc.relation.page | 75 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2007-07-25 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 藥理學研究所 | zh_TW |
| 顯示於系所單位: | 藥理學科所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-96-1.pdf 未授權公開取用 | 3.42 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
